Tag : Rheumatology

Latest News

Rheumatoid arthritis linked to other diseases before and after diagnosis, shows study

Newsemia
A Mayo Clinic-led study involving 3,276 patients has found that people with inflammatory bowel disease, Type 1 diabetes or blood clots may be at increased...
Latest News

Opioids do not improve quality of life or depression in OA patients

Newsemia
New research presented at the 2019 ACR/ARP Annual Meeting suggests that opioids contribute no measurable benefit to quality of life or depression for patients with...
Latest News

Research highlights benefits of oral prednisolone in patients with hand osteoarthritis

Newsemia
Research presented at the 2019 ACR/ARP Annual Meeting found that a six-week treatment with low-dose oral prednisolone substantially improves pain and decreases signs of inflammation...
Latest News

Atmospheric and environmental changes linked to organ-specific lupus flares

Newsemia
New research findings presented at the 2019 ACR/ARP Annual Meeting found a strong association between changes in atmospheric and environmental variables 10 days before a...
Latest News

Additional medications needed to control the symptoms of juvenile idiopathic arthritis

Newsemia
According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, there is a profound ongoing need for additional medications to control...
Latest News

OrthoTrophix Presents Evidence for Disease Modification in Knee Osteoarthritis by TPX-100 at American College of Rheumatology Annual Meeting

Newsemia
OAKLAND, Calif.–(BUSINESS WIRE)–Clinical improvements in knee osteoarthritis by TPX-100 treatment were linked to significant reduction of pathological bone shape change. Source link...
Latest News

FAU physician secures ERC Starting Grant of 1.5 million euros for cutting-edge research

Newsemia
Physician Dr. Andreas Ramming from Friedrich-Alexander-Universität Erlangen-Nürnberg has succeeded in securing research funding in one of the toughest European selection processes. Source link...
Latest News

FDA expands approval of cystic fibrosis treatment to include pediatric patients as young as 6 years old

Newsemia
The U.S. Food and Drug Administration today expanded the indication for Symdeko (a combination of tezacaftor/ivacaftor) tablets for treatment of pediatric patients ages 6 years...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World